Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori enzymes and bacterial adhesion machinery represent a suite of critical proteins required for the survival, colonization, and pathogenicity of H. pylori within the acidic environment of the human stomach. The enzyme urease is particularly vital, as it catalyzes the hydrolysis of urea to produce ammonia, thereby neutralizing gastric acid and creating a habitable neutral pH microenvironment (StatPearls, 2023). Bacterial adhesins, such as BabA and SabA, allow the pathogen to anchor itself to the gastric mucosa, preventing clearance by peristalsis and facilitating the delivery of virulence factors. Bismuth-containing drugs target these systems by binding to the sulfhydryl groups of enzymes and interfering with the assembly of the bacterial cell wall and adhesion complexes (Ge et al., 2012). This multi-targeted approach effectively inhibits H. pylori growth and reduces its ability to cause inflammation and ulceration, making bismuth a cornerstone of quadruple therapy for H. pylori eradication, especially in regions with high antibiotic resistance.
Bismuth ions (Bi3+) exert antimicrobial effects by binding to the essential thiol (sulfhydryl) groups of various bacterial enzymes, such as urease and alcohol dehydrogenase, leading to their irreversible inactivation. Additionally, bismuth interferes with the bacterial adhesion machinery by downregulating the expression of adhesins like BabA and SabA and disrupting the structural integrity of the bacterial cell wall and membrane (Ge et al., 2012; Sun et al., 2004).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori enzymes and bacterial adhesion machinery.